319 related articles for article (PubMed ID: 23246411)
1. [Epidemiology of acromegaly in Spain].
Sesmilo G
Endocrinol Nutr; 2013 Oct; 60(8):470-4. PubMed ID: 23246411
[TBL] [Abstract][Full Text] [Related]
2. Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
Sesmilo G; Webb SM;
Endocrinol Nutr; 2010 Feb; 57(2):39-42. PubMed ID: 20189894
[No Abstract] [Full Text] [Related]
3. [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición].
Cordido F; García Arnés JA; Marazuela Aspiroz M; Torres Vela E;
Endocrinol Nutr; 2013 Oct; 60(8):457.e1-457.e15. PubMed ID: 23660006
[No Abstract] [Full Text] [Related]
4. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
5. [Abnormalities of carbohydrate metabolism in acromegaly].
Biagetti B; Obiols G; Valladares S; Arnez L; Dalama B; Mesa J
Med Clin (Barc); 2013 Nov; 141(10):442-6. PubMed ID: 24012444
[TBL] [Abstract][Full Text] [Related]
6. Medical progress: Acromegaly.
Melmed S
N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
[No Abstract] [Full Text] [Related]
7. [Outcome of somatostatin analogue treatment in acromegaly].
Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
9. Current pharmacotherapy for acromegaly: a review.
Biermasz NR; Romijn JA; Pereira AM; Roelfsema F
Expert Opin Pharmacother; 2005 Nov; 6(14):2393-405. PubMed ID: 16259571
[TBL] [Abstract][Full Text] [Related]
10. [Optimization of the medical treatment for acromegaly].
Díez JJ; Iglesias P
Med Clin (Barc); 2013 Apr; 140(8):360-5. PubMed ID: 23103101
[TBL] [Abstract][Full Text] [Related]
11. Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal Study.
Chiloiro S; Bima C; Tartaglione T; Giampietro A; Gessi M; Lauretti L; Anile C; Colosimo C; Rindi G; Pontecorvi A; De Marinis L; Bianchi A
J Clin Endocrinol Metab; 2019 Nov; 104(11):5478-5482. PubMed ID: 31219586
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
Matsubayashi K; Kawakami K
Endocr J; 2020 Oct; 67(10):997-1006. PubMed ID: 32522909
[TBL] [Abstract][Full Text] [Related]
13. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
14. [Novel pharmacologic therapies in acromegaly].
Góth M; Hubina E; Kovács L; Szabolcs I
Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center.
Van Rompaey K; Unuane D; Moens M; Duerinck J; Poppe K; Velkeniers B; D'Haens J
Acta Neurol Belg; 2013 Mar; 113(1):49-54. PubMed ID: 22975835
[TBL] [Abstract][Full Text] [Related]
16. Management of endocrine disease: GH excess: diagnosis and medical therapy.
Andersen M
Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of acromegaly: a current perspective.
Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
[TBL] [Abstract][Full Text] [Related]
18. Pegvisomant: Balance after 10 years.
Bernabeu I; Marazuela M
Endocrinol Nutr; 2015 Oct; 62(8):363-5. PubMed ID: 26242927
[No Abstract] [Full Text] [Related]
19. Epidemiology of acromegaly in Ecuador.
López Gavilanez E; Guerrero Franco K; Solórzano Zambrano N; Navarro Chávez M; López Estrella C; Vaca Burbano L; Marriott Díaz E
Endocrinol Nutr; 2016; 63(7):333-8. PubMed ID: 27158065
[TBL] [Abstract][Full Text] [Related]
20. Current therapy and drug pipeline for the treatment of patients with acromegaly.
Kumar SS; Ayuk J; Murray RD
Adv Ther; 2009 Apr; 26(4):383-403. PubMed ID: 19444656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
